Addressing Security Challenges: Protecting Proprietary Data in the Cloud
San Francisco-based, publicly traded cell therapy company (LYEL), Lyell Immunopharma, is a cloud-first company for which operations rely on cloud services, where they generate and store proprietary data.
After a thorough requirements definition and series of vendor evaluations, Lyell determined that only Fidelis CloudPassage Halo® provided the means to programmatically define configuration via APIs, allowing it to be seamlessly integrated into Lyell’s automated CICD and Software Development Life Cycle (SDLC) processes.
“Policy assignments work surprisingly well. I can just set policies for our assets and servers, and those policies apply to any new instances that we spin up.”- Eric Hoffmann, Staff Software Engineer, DevSecOps
Read the case study to know the results of Fidelis Halo in Lyell Immunopharma’s cyber environment.